Thermo Fisher Concludes Phadia Buy (ILMN) (LIFE) (TMO)
Recently, Thermo Fisher Scientific ( TMO ) completed the previously announced acquisition of Phadia. In May 2011, the company had decided to acquire Phadia for €2.47 billion (approximately $3.5 billion) in cash from European private equity firm Cinven. Phadia, based in Uppsala, Sweden, is a leading player in allergy and autoimmunity diagnostics. […]